SI-BONE, Inc. (SIBN) financials: revenue, earnings and cash flow
Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
SI-BONE’s revenue went from $48M in fiscal 2017 to $201M in fiscal 2025, growth of about 19.6% a year.
Net income in fiscal 2025 was -$19M, a net margin of -9.4%; the best year in this period was 2018 with -$17M.
Over the twelve months to September 30, 2026, revenue was $221M and net income -$14M.
Free cash flow was -$9M in fiscal 2025 and positive in 0 of the 9 years shown.
The diluted share count rose 1139% over the period (dilution).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $221M | $201M | $167M | $139M | $106M | $90M | $73M | $67M | $55M | $48M |
| Gross profit | $175M | $160M | $132M | $109M | $91M | $80M | $64M | $61M | $51M | $43M |
| Operating income | -$17M | -$22M | -$35M | -$47M | -$60M | -$52M | -$39M | -$36M | -$12M | -$17M |
| Net income | -$14M | -$19M | -$31M | -$43M | -$61M | -$57M | -$44M | -$38M | -$17M | -$23M |
| EPS (diluted) | $-0.31 | $-0.44 | $-0.75 | $-1.13 | $-1.79 | $-1.71 | $-1.50 | $-1.55 | $-2.20 | $-6.65 |
| R&D | $18M | $17M | $17M | $15M | $14M | $12M | $9M | $7M | $5M | $6M |
| Revenue growth | — | +20.2% | +20.4% | +30.5% | +18.0% | +22.8% | +9.0% | +21.5% | +15.4% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6M | -$675000 | -$12M | -$19M | -$42M | -$40M | -$31M | -$32M | -$15M | -$18M |
| Capital spending | -$10M | -$8M | -$10M | -$8M | -$10M | -$6M | -$3M | -$2M | -$942000 | -$478000 |
| Free cash flow | -$4M | -$9M | -$23M | -$27M | -$51M | -$46M | -$33M | -$34M | -$15M | -$18M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | $38000 | $73000 | $0 |
| Stock-based pay | $24M | $26M | $26M | $24M | $23M | $17M | $12M | $7M | $2M | $1M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $42M | $35M | $33M | $97M | $147M | $196M | $92M | $122M | $22M |
| Debt | — | $37M | $37M | $39M | $39M | $40M | $43M | $39M | $39M | $39M |
| Equity | — | $178M | $167M | $169M | $98M | $134M | $169M | $63M | $90M | -$129M |
| Total assets | — | $239M | $230M | $230M | $158M | $191M | $223M | $117M | $139M | $36M |
| Shares (diluted) | 45M | 43M | 41M | 38M | 34M | 33M | 29M | 25M | 8M | 3M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 79.4% | 79.6% | 79.0% | 78.8% | 85.2% | 88.4% | 87.9% | 89.9% | 91.3% | 89.3% |
| Operating margin | -7.6% | -11.1% | -21.1% | -33.8% | -56.0% | -57.3% | -52.5% | -53.5% | -21.6% | -36.2% |
| Net margin | -6.2% | -9.4% | -18.5% | -31.2% | -57.6% | -62.7% | -59.5% | -57.1% | -31.5% | -48.0% |
| FCF margin | -1.9% | -4.5% | -13.7% | -19.1% | -48.1% | -50.9% | -45.3% | -50.6% | -27.9% | -37.5% |
| ROIC | — | -8.2% | -13.6% | -17.8% | -34.2% | -23.3% | -14.3% | -27.8% | -9.3% | — |
| ROE | — | -10.7% | -18.5% | -25.6% | -62.3% | -42.1% | -25.8% | -61.0% | -19.4% | 17.8% |
Frequently asked questions
What is SI-BONE’s annual revenue?
$201M in fiscal 2025 and $221M over the twelve months to September 30, 2026.
How much profit does SI-BONE make?
Net income was -$19M in fiscal 2025 (net margin -9.4%).
Is SI-BONE’s revenue growing?
Yes: revenue rose 20.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.